Sp Asset Management LLC Bristol Myers Squibb CO Transaction History

Sp Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $2,535 - $3,338	63 Added 1.14%	5,579 $231,000
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $94,904 - $107,603	-1,978 Reduced 26.39%	5,516 $299,000
Q4 2023 Feb 07, 2024	BUY	$48.48 - $57.85 $4,023 - $4,801	83 Added 1.12%	7,494 $384,000
Q3 2023 Nov 03, 2023	BUY	$57.89 - $64.73 $3,994 - $4,466	69 Added 0.94%	7,411 $430,000
Q2 2023 Aug 03, 2023	BUY	$63.71 - $70.74 $3,950 - $4,385	62 Added 0.85%	7,342 $469,000
Q1 2023 May 05, 2023	BUY	$65.71 - $74.53 $3,679 - $4,173	56 Added 0.78%	7,280 $504,000
Q4 2022 Feb 01, 2023	BUY	$68.48 - $81.09 $494,699 - $585,794	7,224 New	7,224 $0

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Sp Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sp Asset Management LLC with notifications on news.